Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

HNX:DP3 Revenue

In the year 2025, Central Pharmaceutical Joint Stock Company No3 had annual revenue of 438.01B VND with 4.92% growth. Central Pharmaceutical Joint Stock Company No3 had revenue of 131.63B in the quarter ending December 31, 2025, with 13.30% growth.

• Revenue: 438.01B
• Revenue Growth: +4.92%
• P/S Ratio: 3.11
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.36T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	438.01B	20.52B	4.92%
Dec 31, 2024	417.49B	7.75B	1.89%
Jan 1, 2024	409.73B	-75.34B	-15.53%
Dec 31, 2022	485.07B	104.00B	27.29%
Dec 31, 2021	381.08B	-14.64B	-3.70%